Medical News

RSS

Ardea Biosciences second-quarter total revenues decline to $3.5 million

Ardea Biosciences, Inc., a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases, reported recent accomplishments and financial results for the second quarter and six months ended June 30, 2010.

7 Aug 2010

Researchers examine differences in eating habits of African Americans

Researchers looking for differences in eating habits of African Americans based on whether or not they had Type 2 diabetes uncovered an unexpected result: No matter what the blood sugar level was, the dietary intakes were pretty much the same.

7 Aug 2010

ADA commends U.S. Senate on reauthorization of child nutrition programs

The American Dietetic Association commends the U.S. Senate for its bipartisan action Thursday, August 5, to reauthorize the nation's crucial child nutrition programs. The Healthy, Hunger-Free Kids Act of 2010 covers programs reaching millions of children that were scheduled expire September 30.

7 Aug 2010

Chicago's mold count increases to 49,789, says allergist

Chicago's mold count is 49,789 - just a few spores away from the 50,000 threshold that signals a dangerous air quality warning. Today's mold count is the highest of the season, and the highest in five years. "Headaches, sinus congestion, runny noses and fatigue will be common among Chicagoans," says Dr Joseph Leija, allergist at Loyola's Gottlieb Memorial Hospital

7 Aug 2010

First Salmonella lawsuit filed against Yum Brands

The first Salmonella lawsuit has been filed in the pair of Salmonella outbreaks that has sickened 155 people in 21 states. The lawsuit was filed against Yum! Brands (the parent company of Taco Bell) in the Commonwealth of Kentucky, Franklin County Circuit Court. The lawsuit was filed on behalf of a Scott county resident by food safety law firm Marler Clark.

7 Aug 2010

Orexigen second-quarter net loss decreases to $11.9 million

Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.

7 Aug 2010

Bacterin International closes private placement

Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.

7 Aug 2010

BioSpecifics Technologies second-quarter total revenues decrease to $0.9 million

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced its financial results for the second quarter ended June 30, 2010. The Company's partner, Auxilium Pharmaceuticals, Inc. markets XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class, orphan-designated, biologic, for the treatment of adult Dupuytren's contracture patients with a palpable cord.

7 Aug 2010

Department of Agriculture advises consumers to discard Jersey Hollow Farm's raw milk

The Department of Agriculture today advised consumers who purchased raw milk from Norman Z. and Edith B. Sauder, of Jersey Hollow Farm in Kutztown, Berks County, to discard the product immediately because of potential bacterial contamination.

7 Aug 2010

New superfood Ideal Omega Taste launched with free 'Omega Ice Cream' giveaway

There was mayhem on Blackpool's South Pier yesterday, as Ideal Omega Taste was launched with a free 'Omega Ice Cream' giveaway. The launch proved the new 'fish oil' superfood is delicious enough to be eaten by young and old alike.

7 Aug 2010

Omnicare second-quarter earnings per diluted share decrease to 18 cents

Omnicare, Inc., one of the nation's leading providers of pharmaceutical care for the elderly, reported today financial results for its second quarter ended June 30, 2010.

7 Aug 2010

Patient navigator program to educate Hmong women on cervical cancer

The Asian-American community of Hmong women in California carries a stunning burden of cervical cancer and resulting mortality four times as high as non-Hispanic white women in California do.

7 Aug 2010

US Department of Justice closes investigation of proposed Phase Forward acquisition by Oracle

Phase Forward Incorporated, a leading provider of data management solutions for clinical trials and drug safety, announced that the United States Department of Justice has closed its investigation of the proposed acquisition of Phase Forward by Oracle Corporation, and that the waiting period under the Hard-Scott-Rodino Antitrust Improvements Act of 1976 regarding the Merger has been terminated.

7 Aug 2010

BMS to join ranks of AIDS drug companies to offer price concessions

Bristol-Myers Squibb will soon announce an agreement that will provide additional cost savings to cash-strapped ADAPs nationwide. The agreement, with the ADAP Crisis Task Force (ACTF) of the National Alliance of State & Territorial AIDS Directors, is expected to be announced any day. BMS has been the target of a sustained advocacy campaign led by AHF over its pricing of its key AIDS drug Reyataz.

7 Aug 2010

Ideasbynet to lend support for World Mental Health Day

Ideasbynet has announced it is to lend its support to the UK Mental Health Foundation as part of World Mental Health Day, taking place on the 10th October.

7 Aug 2010

Halozyme second-quarter revenue increases to $3.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.

7 Aug 2010

MDinsight clinical quality system to help hospitals, physicians achieve meaningful use requirements

MDdatacor, Inc., a leader in health care quality management solutions for insurers and health care providers, today announced that its MDinsight clinical quality system will help hospitals and physicians achieve many of the meaningful use requirements as outlined in the recently announced final rules of the HITECH Act.

7 Aug 2010

Shlomo Melmed appointed to Independent Citizen's Oversight Committee

Shlomo Melmed, M.D., senior vice president for academic affairs and dean of the medical faculty at Cedars-Sinai Medical Center, has been appointed by Gov. Arnold Schwarzenegger to the Independent Citizen's Oversight Committee, the governing board of the California Institute for Regenerative Medicine.

7 Aug 2010

Study generates promising data about sustained durability of Zyclara's efficacy versus cryosurgery alone

Results from a randomized study with Zyclara following cryotherapy in the treatment of actinic keratoses (AK) demonstrated Zyclara complemented the effectiveness of cryosurgery in reducing total AK count and achieving complete clearance of AK, according to data presented at the American Academy of Dermatology Summer Academy Meeting 2010 (Summer AAD), August 4 - 8.

7 Aug 2010

Northstar Healthcare receives advance from CHA

Northstar Healthcare Inc. today announced that it received an advance in the amount of Cdn.$1,016,150 from Canada Healthcare Acquisition Inc., a corporation indirectly controlled by Dr. Donald L. Kramer, M.D., a former CEO and former director of Northstar.

7 Aug 2010